Authors:
Bernstein, PR
Aharony, D
Albert, JS
Andisik, D
Barthlow, HG
Bialecki, R
Davenport, T
Dedinas, RF
Dembofsky, BT
Koether, G
Kosmider, BJ
Kirkland, K
Ohnmacht, CJ
Potts, W
Rumsey, WL
Shen, LH
Shenvi, A
Sherwood, S
Stollman, D
Russell, K
Citation: Pr. Bernstein et al., Discovery of novel, orally active dual NK1/NK2 antagonists, BIOORG MED, 11(20), 2001, pp. 2769-2773
Authors:
Rumsey, WL
Aharony, D
Bialecki, RA
Abbott, BM
Barthlow, HG
Caccese, R
Ghanekar, S
Lengel, D
McCarthy, M
Wenrich, B
Undem, B
Ohnmacht, C
Shenvi, A
Albert, JS
Brown, F
Bernstein, PR
Russell, K
Citation: Wl. Rumsey et al., Pharmacological characterization of ZD6021: A novel, orally active antagonist of the tachykinin receptors, J PHARM EXP, 298(1), 2001, pp. 307-315
Authors:
Veale, CA
Alford, VC
Aharony, D
Banville, DL
Bialecki, RA
Brown, FJ
Damewood, JR
Dantzman, CL
Edwards, PD
Jacobs, RT
Mauger, RC
Murphy, MM
Palmer, WE
Pine, KK
Rumsey, WL
Garcia-Davenport, LE
Shaw, A
Steelman, GB
Surian, JM
Vacek, EP
Citation: Ca. Veale et al., The discovery of non-basic atrial natriuretic peptide clearance receptor antagonists. Part 1, BIOORG MED, 10(17), 2000, pp. 1949-1952